(2'R)-2'-DEOXY-2'-FLUORO-2'-METHYL-5'-URIDYLIC ACID (25 mg) ([(2R,3R,4R,5R)-5-[2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl]methyl dihydrogen phosphate)

(2’R)-2′-DEOXY-2′-FLUORO-2′-METHYL-5′-URIDYLIC ACID (25 mg) ([(2R,3R,4R,5R)-5-[2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl]methyl dihydrogen phosphate)

In Stock

Ready to ship

Catalogue No.

1A12790

CAS No.

1015073-43-4

Molecular Formula

C₁₀H₁₄FN₂O₈P

Product Type

Pharmaceutical Analytical Impurities

$725.00

Shipping information

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Additional information

Current Lot Information

Current Lot:

F278Y0

CAS RN®

1015073-43-4

Harmonized System (HS) Code *:

29349990

UN No:

N/A

NDC No:

N/A

Molecular Formula

C₁₀H₁₄FN₂O₈P

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No	USP Certificates/Product Information Sheets and Valid Use Dates	Valid Use Date	Country of Origin*	Material Origin*
F278Y0	1A12790-F278Y0	See Product Information Sheet	India	Chemical Synthesis


Lot No F278Y0	USP Certificates/Product Information Sheets and Valid Use Dates Chemical Synthesis
Valid Use Date See Product Information Sheet
Country of Origin* India
Material Origin* No data available

Lot No

F278Y0

USP Certificates/Product Information Sheets and Valid Use Dates

Chemical Synthesis

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

No data available

Frequently bought together

(2'R)-2'-DEOXY-2'-FLUORO-2'-METHYL-5'-URIDYLIC ACID (25 mg) ([(2R,3R,4R,5R)-5-[2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl]methyl dihydrogen phosphate)

Catalogue No.

1A12790

CAS No.

1015073-43-4

Molecular Formula

C₁₀H₁₄FN₂O₈P

Product Type

Pharmaceutical Analytical Impurities

$725.00

OXINDOLE

Catalogue No.

1A09990

CAS No.

59-48-3

Molecular Formula

C₈H₇NO

Product Type

Pharmaceutical Analytical Impurities

$475.00

4-CHLORO BUPROPION HYDROCHLORIDE

Catalogue No.

1A06470

CAS No.

1346598-72-8

Molecular Formula

C₁₃H₁₇Cl₂NO.HCl

Product Type

Pharmaceutical Analytical Impurities

$725.00

7-BENZOYL KETOROLAC (25 mg) (7-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid)

ETHYL NINTEDANIB (25 mg) (Ethyl (Z)-3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}amino)(phenyl)methylene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate )

REGADENOSON ACID (25 mg) (1-(6-Amino-9-β-D-ribofuranosyl-9H-purin-2-yl)-1H-pyrazole-4-carboxylic acid )

3-METHOXY APIXABAN (25 mg) (1-(3-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide )

LERCANIDIPINE HYDROCHLORIDE (100 mg) ((2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl methyl (4RS)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate monohydrochloride))

α-ESTRADIOL BENZOATE (25 mg) (17α-Hydroxyestra-1,3,5(10)-trien-3-yl benzoate)

RITONAVIR ISOBUTOXYCARBONYL AMINOALCOHOL (25 mg) (Thiazol-5-ylmethyl (2S,3S,5S)-(5-isobutoxycarbonylamino)-3-hydroxy-1,6-diphenylhexan-2-ylcarbamate)

RANOLAZINE BIS N-OXIDE (25 mg) (N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine acetamide 1,4-dioxide)

3-CHLORO CETIRIZINE (25 mg) (2-[2-[4-[(3-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid )

APALUTAMIDE ACID (25 mg) (4-(7-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluorobenzoic acid )